The National Institutes of Health (NIH) is launching a Phase 3 clinical trial to determine the efficacy of tecovirimat — the smallpox antiviral better known as TPOXX — for use in treating monkeypox, ...

Before this summer, monkeypox was practically unheard of in the U.S. But, now that the country has confirmed more than 7,500 cases, there are a lot of questions about monkeypox treatment. Here’s the ...

Joseph Cassara decided to head back to the emergency room when the pain made it unbearable to swallow. “I tried to eat a banana for breakfast,” he said, “and it just felt like I was swallowing razor ...

SIGA Technologies is a specialty pharmaceutical company that develops and sells antiviral medicines focused on biodefense. Its lead product, TPOXX, comes in oral and intravenous (IV) formulations and ...

Nguyen indicated ongoing engagement with the U.S. government for future TPOXX procurement and noted, "we expect multiple international sales in 2026" based on current stakeholder interest. The company ...